Triple

T16851973
Position Surface form Disambiguated ID Type / Status
Subject Biktarvy E409696 entity
Predicate hasActiveIngredient P12771 FINISHED
Object bictegravir
Bictegravir is an integrase strand transfer inhibitor (INSTI) antiretroviral drug used in combination regimens for the treatment of HIV-1 infection.
 E409696 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: bictegravir | Statement: [Biktarvy, hasActiveIngredient, bictegravir]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: bictegravir
Context triple: [Biktarvy, hasActiveIngredient, bictegravir]
  • A. Truvada
    Truvada is a prescription antiretroviral medication widely used both to treat HIV infection and as pre-exposure prophylaxis (PrEP) to help prevent HIV in high-risk individuals.
  • B. Descovy
    Descovy is a prescription antiretroviral medication from Gilead Sciences used for the treatment and prevention (PrEP) of HIV-1 infection.
  • C. Biktarvy
    Biktarvy is a prescription combination antiretroviral medication used to treat HIV-1 infection in adults and certain children.
  • D. velpatasvir
    Velpatasvir is a direct-acting antiviral medication used in combination with sofosbuvir to treat chronic hepatitis C virus infection across multiple genotypes.
  • E. Sovaldi
    Sovaldi is a breakthrough antiviral medication used to treat chronic hepatitis C by directly inhibiting the virus’s replication.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: bictegravir
Triple: [Biktarvy, hasActiveIngredient, bictegravir]
Generated description
Bictegravir is an integrase strand transfer inhibitor (INSTI) antiretroviral drug used in combination regimens for the treatment of HIV-1 infection.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: bictegravir
Target entity description: Bictegravir is an integrase strand transfer inhibitor (INSTI) antiretroviral drug used in combination regimens for the treatment of HIV-1 infection.
  • A. Truvada
    Truvada is a prescription antiretroviral medication widely used both to treat HIV infection and as pre-exposure prophylaxis (PrEP) to help prevent HIV in high-risk individuals.
  • B. Descovy
    Descovy is a prescription antiretroviral medication from Gilead Sciences used for the treatment and prevention (PrEP) of HIV-1 infection.
  • C. Biktarvy chosen
    Biktarvy is a prescription combination antiretroviral medication used to treat HIV-1 infection in adults and certain children.
  • D. velpatasvir
    Velpatasvir is a direct-acting antiviral medication used in combination with sofosbuvir to treat chronic hepatitis C virus infection across multiple genotypes.
  • E. Sovaldi
    Sovaldi is a breakthrough antiviral medication used to treat chronic hepatitis C by directly inhibiting the virus’s replication.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d88395e6c88190b22730f335107c14 completed April 10, 2026, 4:59 a.m.
NER Named-entity recognition batch_69e3b379b8fc81908d8bc9950c7f8bad completed April 18, 2026, 4:38 p.m.
NED1 Entity disambiguation (via context triple) batch_6a00bb216fac81909d401c6b9911d1e0 completed May 10, 2026, 5:06 p.m.
NEDg Description generation batch_6a00bb9b2b1881908f9f5c3dd1a2d500 completed May 10, 2026, 5:08 p.m.
NED2 Entity disambiguation (via description) batch_6a00bc3a4b888190bd190b9330e2777d completed May 10, 2026, 5:11 p.m.
Created at: April 10, 2026, 5:24 a.m.